MedTech Dive - Latest News

Buying tissue-healing company AMS will bring H.B. Fuller into the markets for formulated biosurgicals and mechanical closures.

CHAI plans to create playbooks to help organizations defend against — and leverage — these powerful systems.

An outside party gained access to some company systems, but the medical device maker found no evidence that sensitive or protected data was obtained and said its operations are running normally.

European private equity firm Astorg will run the business as an independent diagnostics company, led by former PerkinElmer CEO Dirk Bontridder.

BD called completing enrollment in the study “a significant milestone in its advanced tissue regeneration strategy and expansion efforts.”